1. Home
  2. NRSN vs ASRV Comparison

NRSN vs ASRV Comparison

Compare NRSN & ASRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • ASRV
  • Stock Information
  • Founded
  • NRSN 2017
  • ASRV 1983
  • Country
  • NRSN Israel
  • ASRV United States
  • Employees
  • NRSN N/A
  • ASRV N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • ASRV Major Banks
  • Sector
  • NRSN Health Care
  • ASRV Finance
  • Exchange
  • NRSN Nasdaq
  • ASRV Nasdaq
  • Market Cap
  • NRSN 50.1M
  • ASRV 51.0M
  • IPO Year
  • NRSN 2021
  • ASRV N/A
  • Fundamental
  • Price
  • NRSN $1.77
  • ASRV $2.80
  • Analyst Decision
  • NRSN Buy
  • ASRV
  • Analyst Count
  • NRSN 2
  • ASRV 0
  • Target Price
  • NRSN $14.00
  • ASRV N/A
  • AVG Volume (30 Days)
  • NRSN 225.6K
  • ASRV 29.0K
  • Earning Date
  • NRSN 08-05-2025
  • ASRV 07-22-2025
  • Dividend Yield
  • NRSN N/A
  • ASRV 4.20%
  • EPS Growth
  • NRSN N/A
  • ASRV N/A
  • EPS
  • NRSN N/A
  • ASRV 0.22
  • Revenue
  • NRSN N/A
  • ASRV $51,581,000.00
  • Revenue This Year
  • NRSN N/A
  • ASRV N/A
  • Revenue Next Year
  • NRSN N/A
  • ASRV N/A
  • P/E Ratio
  • NRSN N/A
  • ASRV $12.88
  • Revenue Growth
  • NRSN N/A
  • ASRV 13.95
  • 52 Week Low
  • NRSN $0.60
  • ASRV $2.03
  • 52 Week High
  • NRSN $2.60
  • ASRV $3.42
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 39.25
  • ASRV 36.74
  • Support Level
  • NRSN $1.69
  • ASRV $2.73
  • Resistance Level
  • NRSN $2.09
  • ASRV $2.99
  • Average True Range (ATR)
  • NRSN 0.15
  • ASRV 0.14
  • MACD
  • NRSN -0.04
  • ASRV -0.05
  • Stochastic Oscillator
  • NRSN 17.78
  • ASRV 11.86

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About ASRV AmeriServ Financial Inc.

AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.

Share on Social Networks: